Identification and Characterization of A Novel Gene, HSG
Identification and Characterization of A Novel Gene, HSG
批准号:
6814956
负责人:
Rui-Ping Xiao
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
angiogenesis biotechnology cell growth regulation cell proliferation cytogenetics differential display technique fibroblast growth factor gene expression gene induction /repression genetic mapping hyperplasia myogenesis platelet derived growth factor spontaneous hypertensive rat tissue /cell culture vascular smooth muscle
中文摘要
血管增殖性疾病,如动脉粥样硬化和球囊血管成形术后再狭窄,在心血管疾病中起着核心作用,心血管疾病是目前西方国家的主要死亡原因,预计到2020年将成为全球头号杀手,但其潜在的分子机制尚不清楚。通过对自发性高血压大鼠(SHR)和年龄、性别匹配的Wistar Kyoto大鼠(WKY)培养血管平滑肌细胞(VSMCs)的RNA差异显示分析,我们发现了一个名为增生抑制基因(HSG)的新基因,该基因编码757个氨基酸的蛋白,在大鼠各种组织中广泛表达。我们还克隆了人和小鼠HSG基因,与大鼠HSG (rHSG)的序列同源性分别为95.2%和98.4%。与正常WKY VSMCs相比,增生性SHR VSMCs中rHSG的表达明显下调。此外,rHSG的表达也被增殖刺激因子如血小板衍生生长因子(PDGF)明显下调。培养的原代WKY VSMCs中碱性成纤维细胞生长因子(bFGF)和内皮素-1 (ET-1)的表达。通过腺病毒基因转移强化表达rHSG,通过抑制ERK1/2 MAPK激活和随后的G1/Go细胞周期阻滞,显著抑制生长因子介导的VSMC增殖,并在体内减少90%球囊损伤诱导的新内膜形成,从而防止球囊损伤相关的再狭窄。因此,我们发现并鉴定了一个广泛表达和高度保守的新基因HSG,它在调节VSMC增殖中发挥重要作用,可能为血管增生性疾病的治疗提供潜在的分子靶点。
英文摘要
Vascular proliferative disorders such as atherosclerosis and restenosis after balloon angioplasty play a central role in cardiovascular diseases, the current leading cause of death in the western countries and the predicted number one killer worldwide by 2020, but the underlying molecular mechanism is poorly understood. Using RNA differential display analysis in cultured vascular smooth muscle cells (VSMCs) from spontaneously hypertensive rats (SHR) and age- and gender-matched Wistar Kyoto rats (WKY), we have identified a novel gene, named hyperplasia suppressor gene (HSG) which encodes a protein of 757 amino acids and is widely expressed in various rat tissues. We have also cloned human and mouse HSG genes, which share 95.2 and 98.4 % sequence homology, respectively, with rat HSG (rHSG). The expression of rHSG is markedly downregulated in hyperplasic SHR VSMCs relative to normal WKY VSMCs. In addition, rHSG expression is also overtly down-regulated by proliferation-stimulating factors such as platelet-derived growth factor (PDGF)?Cbasic fibroblast growth factor (bFGF), and endothelin-1 (ET-1) in cultured primary WKY VSMCs. Enforced expression of rHSG using adenoviral gene transfer markedly inhibits growth factors-mediated VSMC proliferation by inhibition of ERK1/2 MAPK activation and subsequent cell cycle arrest in G1/Go, and reduces balloon injury-induced neointimal formation by 90% in vivo, thereby preventing balloon injury-associated restenosis. Thus, we have identified and characterized a widely expressed and highly conserved novel gene, HSG, which exhibits an important role in regulating VSMC proliferation, and might provide a potential molecular target for the treatment of vascular proliferative disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CaMKII-dB and CaMKII-dC Oppositely Regulate Cardiomyocyte viability
-
批准号:7591974
-
项目类别:
-
资助金额:$65.47万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Pi3k Gs Signal Control During B2-adrenergic stimulation
-
批准号:6674194
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Intracellular Acidosis-Activated p38 MAPK & Hypoxia
-
批准号:6969624
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Cardiac Excitation-Contraction Coupling by p38 MAPK
-
批准号:6815451
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
B-Arrestin2 Is Required for BAR Resensitization But Not its Desensitization
-
批准号:7732333
-
项目类别:
-
资助金额:$37.94万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
B-Arrestin2 Is Required for BAR Resensitization But Not
-
批准号:7327091
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
B-Arrestin2 Is Required for BAR Resensitization But Not its Desensitization
-
批准号:7592069
-
项目类别:
-
资助金额:$46.76万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Mitochondrial Protein HSG Is a Major Determinant of Oxid
-
批准号:7327023
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Dysregulation of HSG Triggers Proliferative Disorders
-
批准号:6968763
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Suppression of Beta-arrestin1 Phosphorylation and Function by Beta-arrestin2
-
批准号:7964066
-
项目类别:
-
资助金额:$20.33万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Agonist Stereochemistry Determines Beta2-Adrenergic G Protein Coupling
-
批准号:7964073
-
项目类别:
-
资助金额:$22.59万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Heterodimer of b1-AR and b2-AR Optimizes b-AR Modulation
-
批准号:7132347
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
CaMKII-aB Protects the Heart Against Oxidative-Stress In
-
批准号:7325047
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Heterodimer of b1-AR and b2-AR Optimizes b-AR Modulation
-
批准号:7327060
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
PI3K Offsets b1-Adrenoceptor/PKA-Mediated Positive Inotr
-
批准号:6969617
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Dysregulation of HSG Triggers Cardiomyocyte Apoptosis
-
批准号:7131125
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Agonist Stereochemistry Determines b2-Adrenergic G Protein Coupling Preference
-
批准号:7732340
-
项目类别:
-
资助金额:$19.83万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
RGS2 Constitutes A Negative Regulator of Beta2-Adrenergic Gi Signaling
-
批准号:7732339
-
项目类别:
-
资助金额:$29.32万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Beta1-adrenergic Apoptotic Signal Delivered By CaMKII
-
批准号:6814952
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
Mitochondrial Protein HSG Is A Primary Mediator of Oxidative Apoptotic Death
-
批准号:7591976
-
项目类别:
-
资助金额:$56.12万
-
财政年份:--
-
负责人:Rui-Ping Xiao
-
依托单位:
海外基金